B. Kapogiannis

发表

Disparities in Mental Health Care among HIV-Infected Youth

G. Harper, L. Brown, L. Whiteley, 2014, Journal of the International Association of Providers of AIDS Care.

Prevalence and Risk Factors for HPV in HIV-Positive Young Women Receiving Their First HPV Vaccination

K. Squires, R. Burk, Jiahong Xu, 2012, Journal of acquired immune deficiency syndromes.

Barriers and Facilitators to the Collection and Aggregation of Electronic Health Record HIV Data: An Analysis of Study Recruitment Venues Within the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)

Sung-Jae Lee, B. Kapogiannis, Leah Genn, 2021, Evaluation & the health professions.

Advancing HIV Biomedical Prevention Research for At-Risk Adolescents

G. Siberry, B. Kapogiannis, R. Hazra, 2018, Journal of acquired immune deficiency syndromes.

Accelerating adolescent HIV research in low-income and middle-income countries: evidence from a research consortium

B. Taiwo, J. Iwelunmor, S. Subramanian, 2021, AIDS.

Moral conflict and competing duties in the initiation of a biomedical HIV prevention trial with minor adolescents

J. Fortenberry, G. Zimet, A. Gilbert, 2017, AJOB empirical bioethics.

Advancing independent adolescent consent for participation in HIV prevention research

Seema K. Shah, E. Erbelding, B. Kapogiannis, 2018, Journal of Medical Ethics.

Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth

S. Shrestha, Wei-Zheng Song, B. Kapogiannis, 2009, Human Genetics.

Minors' and Young Adults' Experiences of the Research Consent Process in a Phase II Safety Study of Pre-exposure Prophylaxis for HIV.

J. Fortenberry, G. Zimet, M. Ott, 2017, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Adolescent Self-Consent for Biomedical HIV Prevention Research: Implications for Institutional Review Board Approval and Implementation

J. Fortenberry, G. Zimet, A. Gilbert, 2015 .

The secret life of young adolescents living with HIV in northern Mozambique - a mixed methods study

J. Mantell, B. Kapogiannis, E. Abrams, 2021, BMC Public Health.

Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.

M. Van Loan, K. Mulligan, C. Stephensen, 2012, The Journal of clinical endocrinology and metabolism.

Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?

C. Gordon, M. Van Loan, K. Mulligan, 2013, Antimicrobial Agents and Chemotherapy.

Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.

M. Van Loan, K. Mulligan, C. Stephensen, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Exploration of the Effect of Tobacco Smoking on Metabolic Measures in Young People Living with HIV

D. Harris, G. Aldrovandi, Mark L Rubinstein, 2014, AIDS research and treatment.

Verification of HIV Self-Testing Use and Results: A Global Systematic Review.

J. Iwelunmor, N. Rosenberg, J. Ong, 2020, AIDS patient care and STDs.

Prevalence and risk factors for oral DNA tumor viruses in HIV‐infected youth

Jiahong Xu, E. Secord, M. Gillison, 2016, Journal of medical virology.

Mental health and ART adherence among adolescents living with HIV in Mozambique

I. Wilson, K. Lovero, B. Kapogiannis, 2022, AIDS care.

Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth

E. Leister, G. Siberry, B. Kapogiannis, 2016, AIDS.

Behavioral, Immunologic, and Virologic Correlates of Oral Human Papillomavirus Infection in HIV-Infected Youth

Jiahong Xu, E. Secord, M. Gillison, 2015, Sexually transmitted diseases.

Adolescents in Clinical Trials

D. Mattison, B. Kapogiannis, BG Kapogiannis, 2008, Clinical pharmacology and therapeutics.

Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa

S. Delany-Moretlwe, L. Bekker, S. Hosek, 2016, Journal of the International AIDS Society.

Integrating Behavioral HIV Interventions Into Biomedical Prevention Trials With Youth: Lessons From Chicago's Project PrEPare

S. Hosek, G. Siberry, M. Lally, 2013, Journal of HIV/AIDS & social services.

Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay

Jiahong Xu, J. Sleasman, B. Kapogiannis, 2017, Journal of acquired immune deficiency syndromes.

Fostering successful and sustainable collaborations to advance implementation science: the adolescent HIV prevention and treatment implementation science alliance

L. Bekker, B. Kapogiannis, L. Guay, 2020, Journal of the International AIDS Society.

Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination.

B. Kapogiannis, N. Mehta, K. Luzuriaga, 2010, Vaccine.

Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens

B. Kapogiannis, Craig M. Wilson, B. Rudy, 2011, Journal of acquired immune deficiency syndromes.

Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis.

C. Gordon, K. Mulligan, S. Hosek, 2019, AIDS research and human retroviruses.

Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone

C. Gordon, K. Mulligan, C. Stephensen, 2018, Antiviral therapy.

Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial

Miguel Ángel Martínez, D. Harris, C. Gordon, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulence.

M. Farley, S. Satola, B. Kapogiannis, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adolescent HIV Research Ethics in Resource-Constrained Settings: Low and Middle-Income Country Research Consortium Experience and Scoping Review

C. Slack, S. Day, J. Tucker, 2021 .

Effect of Text Messaging Plus Peer Navigation on Viral Suppression Among Youth With HIV in the iCARE Nigeria Pilot Study

B. Taiwo, B. Berzins, R. Garofalo, 2021, Journal of acquired immune deficiency syndromes.

Characteristics of adolescents aged 15-19 years living with vertically and horizontally acquired HIV in Nampula, Mozambique

L. Myer, J. Mantell, B. Kapogiannis, 2021, PloS one.

The 4 youth by youth HIV self-testing crowdsourcing contest: A qualitative evaluation

C. Airhihenbuwa, J. Iwelunmor, J. Tucker, 2020, PloS one.

The Acceptability and Feasibility of an HIV Preexposure Prophylaxis (PrEP) Trial With Young Men Who Have Sex With Men

S. Hosek, G. Siberry, B. Rutledge, 2013, Journal of acquired immune deficiency syndromes.

Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis

C. Gordon, M. Van Loan, K. Mulligan, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.

D. Harris, G. Aldrovandi, R. Fielding, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Preexposure prophylaxis for adolescents and young adults at risk for HIV infection: is an ounce of prevention worth a pound of cure?

G. Siberry, B. Kapogiannis, R. Hazra, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Randomized Trial to Determine Safety and Immunogenicity of Two Strategies for Hepatitis B Vaccination in Healthy Urban Adolescents in the United States

Jiahong Xu, B. Kapogiannis, Craig M. Wilson, 2010, The Pediatric infectious disease journal.

Rolling up our sleeves now to reap the benefits later: preparing the community for an adolescent HIV vaccine

B. Kapogiannis, Sonia Lee, 2007, Current opinion in HIV and AIDS.

Vitamin D3 Supplementation Increases Fibroblast Growth Factor-23 in HIV-Infected Youths Treated with Tenofovir Disoproxil Fumarate

C. Gordon, M. Van Loan, K. Mulligan, 2014, Antiviral therapy.

Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States

D. Harris, K. Mayer, G. Zimet, 2017, JAMA pediatrics.

Comprehension of a simplified assent form in a vaccine trial for adolescents

D. Hoffman, B. Kapogiannis, Craig M. Wilson, 2013, Journal of Medical Ethics.

The CombinADO study to assess the impact of a combination intervention strategy on viral suppression, antiretroviral therapy adherence, and retention in HIV care among adolescents and young people living with HIV: protocol for a cluster-randomized controlled trial

L. Myer, M. Lesosky, B. Kapogiannis, 2021, Trials.

Correction to: The CombinADO study to assess the impact of a combination intervention strategy on viral suppression, antiretroviral therapy adherence, and retention in HIV care among adolescents and young people living with HIV: protocol for a cluster-randomized controlled trial

L. Myer, M. Lesosky, B. Kapogiannis, 2022, Trials.

Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.

K. Squires, Jiahong Xu, B. Kapogiannis, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ethical Issues in Adolescent HIV Research in Resource-Limited Countries

Seema K. Shah, L. Bekker, C. Slack, 2014, Journal of acquired immune deficiency syndromes.

Transitioning HIV-Positive Adolescents to Adult Care: Lessons Learned From Twelve Adolescent Medicine Clinics.

J. Fortenberry, J. Ellen, B. Kapogiannis, 2016, Journal of pediatric nursing.

Transitioning adolescents with HIV to adult care: Lessons learned from twelve adolescent medicine clinics

J. Fortenberry, J. Ellen, B. Kapogiannis, 2016 .

Two or more significant life-events in 6-months are associated with lower rates of HIV treatment and virologic suppression among youth with HIV in Uganda and Kenya

D. Havlir, M. Kamya, E. Charlebois, 2022, AIDS care.

Trends in Opportunistic Infections in the Pre–and Post–Highly Active Antiretroviral Therapy Eras Among HIV-Infected Children in the Perinatal AIDS Collaborative Transmission Study, 1986–2004

L. Koenig, B. Kapogiannis, M. Soe, 2007, Pediatrics.

Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir-Ritonavir in Adolescents and Young Adults with Human Immunodeficiency Virus Infection

D. Harris, C. Fletcher, B. Kapogiannis, 2007, Antimicrobial Agents and Chemotherapy.

Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study.

S. Spector, L. Peralta, G. Aldrovandi, 2006, The Journal of infectious diseases.

Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women.

D. Szydlo, K. Squires, K. Bunge, 2020, Journal of acquired immune deficiency syndromes.

Changes in Bone Mass After Discontinuation of Pre-Exposure Prophylaxis (PrEP) with Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.

S. Perumean-Chaney, K. Mulligan, S. Hosek, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Preventing HIV Among Young People: Research Priorities for the Future

S. Delany-Moretlwe, S. Bull, L. Bekker, 2013, Journal of acquired immune deficiency syndromes.

Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020

Richard L. Dunville, D. Smith, B. Kapogiannis, 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).

L. Koenig, B. Kapogiannis, M. Soe, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines

P. Goepfert, B. Kapogiannis, H. Robinson, 2007, Journal of Virology.

Executive Summary: Opportunities for Action and Impact to Address HIV and AIDS in Adolescents

B. Kapogiannis, C. Luo, S. Kasedde, 2014, Journal of acquired immune deficiency syndromes.

“Youth friendly” clinics: Considerations for linking and engaging HIV-infected adolescents into care

J. Fortenberry, J. Ellen, B. Kapogiannis, 2014, AIDS care.

Understanding Care Linkage and Engagement Across 15 Adolescent Clinics: Provider Perspectives and Implications for Newly HIV-Infected Youth.

J. Fortenberry, J. Ellen, B. Kapogiannis, 2017, AIDS education and prevention : official publication of the International Society for AIDS Education.

Evidence-Based Programming for Adolescent HIV Prevention and Care: Operational Research to Inform Best Practices

B. Kapogiannis, Sonia Lee, K. Legins, 2014, Journal of acquired immune deficiency syndromes.

Linking HIV-positive adolescents to care in 15 different clinics across the United States: Creating solutions to address structural barriers for linkage to care

J. Fortenberry, J. Ellen, B. Kapogiannis, 2014, AIDS care.

Adolescent participation in HIV research: consortium experience in low and middle-income countries and scoping review.

Seema K. Shah, C. Slack, S. Day, 2020, The lancet. HIV.

Introduction: Paving the Way for Biomedical HIV Prevention Interventions in Youth

M. Ruiz, E. Handelsman, B. Kapogiannis, 2010, Journal of acquired immune deficiency syndromes.

Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.

D. Harris, S. Stoszek, G. Aldrovandi, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Global implementation of PrEP as part of combination HIV prevention – Unsolved challenges

S. Delany-Moretlwe, S. McCormack, T. Hallett, 2016 .

Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061

K. Squires, J. Sleasman, B. Kapogiannis, 2015, Journal of acquired immune deficiency syndromes.

Trends in Bacteremia in the Pre- and Post-Highly Active Antiretroviral Therapy Era Among HIV-Infected Children in the US Perinatal AIDS Collaborative Transmission Study (1986–2004)

L. Koenig, B. Kapogiannis, M. Soe, 2008, Pediatrics.

An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM

K. Mayer, G. Zimet, K. Mulligan, 2017, Journal of acquired immune deficiency syndromes.

Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth pre-exposure prophylaxis services?

S. Delany-Moretlwe, L. Bekker, S. Hosek, 2020, AIDS.

Evaluation of the iCARE Nigeria Pilot Intervention Using Social Media and Peer Navigation to Promote HIV Testing and Linkage to Care Among High-Risk Young Men

B. Taiwo, B. Berzins, R. Garofalo, 2022, JAMA network open.

Youth-Specific Considerations in the Development of Preexposure Prophylaxis, Microbicide, and Vaccine Research Trials

L. Bekker, G. Gray, P. Krogstad, 2010, Journal of acquired immune deficiency syndromes.

The HIV Continuum of Care for Adolescents and Young Adults Attending 13 Urban US HIV Care Centers of the NICHD-ATN-CDC-HRSA SMILE Collaborative.

J. Fortenberry, K. Mayer, Jiahong Xu, 2020, Journal of acquired immune deficiency syndromes.

An assessment of the feasibility and acceptability of a friendship-based social network recruitment strategy to screen at-risk African American and Hispanic/Latina young women for HIV infection.

C. Boyer, J. Ellen, B. Kapogiannis, 2013, JAMA pediatrics.

HIV Continuum of Care for Youth in the United States

J. Fortenberry, A. Westfall, Jiahong Xu, 2017, Journal of acquired immune deficiency syndromes.

Improving the Youth HIV Prevention and Care Continuums: The Adolescent Medicine Trials Network for HIV/AIDS Interventions

B. Kapogiannis, S. Allison, Sonia Lee, 2018, JMIR research protocols.

Research Priorities to End the Adolescent HIV Epidemic in the United States: Viewpoint.

P. Sullivan, J. Parsons, G. Harper, 2020, JMIR research protocols.

Research Priorities to End the Adolescent HIV Epidemic in the United States: Viewpoint

P. Sullivan, J. Parsons, G. Harper, 2020, JMIR research protocols.

Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV

S. Woods, S. Nichols, P. Garvie, 2015, Journal of NeuroVirology.

Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.

S. Woods, S. Nichols, P. Garvie, 2013, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Correlates of HIV Testing History Among Urban Youth Recruited Through Venue-Based Testing in 15 US Cities

J. Ellen, B. Kapogiannis, P. Emmanuel, 2011, Sexually transmitted diseases.

HIV viral load levels and CD4+ cell counts of youth in 14 cities

J. Fortenberry, J. Ellen, Jiahong Xu, 2014, AIDS.

Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.

E. Kabagambe, J. Sleasman, B. Kapogiannis, 2013, AIDS research and human retroviruses.

Profiles of Risk Among HIV-Infected Youth in Clinic Settings

S. Nichols, Jiahong Xu, M. I. Fernandez, 2015, AIDS and Behavior.

The Road to Zero Perinatal HIV Transmission in the United States.

B. Kapogiannis, N. Chakhtoura, 2023, Pediatrics.

Linking HIV-Positive Adolescents Into Care: The Effects of Relationships Between Local Health Departments and Adolescent Medicine Clinics

J. Fortenberry, J. Ellen, M. Ott, 2013, Journal of HIV/AIDS & social services.

Evaluating Testing Strategies for Identifying Youths With HIV Infection and Linking Youths to Biomedical and Other Prevention Services

J. Fortenberry, C. Boyer, R. Miller, 2017, JAMA pediatrics.

Identification of HIV-infected 12- to 24-year-old men and women in 15 US cities through venue-based testing.

D. Harris, J. Ellen, B. Kapogiannis, 2010, Archives of pediatrics & adolescent medicine.

Does Venue Type Matter for HIV-Related Risk Behavior in Urban Adolescent and Young Adult Men Who Have Sex With Men?

C. Boyer, J. Ellen, B. Kapogiannis, 2017 .

Implementation of an Integrated Approach to the National HIV/AIDS Strategy for Improving Human Immunodeficiency Virus Care for Youths

J. Fortenberry, J. Ellen, L. Koenig, 2017, JAMA pediatrics.

A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection.

C. Boyer, L. Peralta, J. Ellen, 2014, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Evaluation of the effect of human immunodeficiency virus-related structural interventions: the connect to protect project.

C. Boyer, J. Ellen, G. Harper, 2015, JAMA pediatrics.

Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.

J. Herndon, P. Nigam, B. Kapogiannis, 2006, AIDS research and human retroviruses.

HIV Testing, Care Referral, and Linkage to Care Intervals Affect Time to Engagement in Care for Newly Diagnosed HIV-Infected Adolescents in 15 Adolescent Medicine Clinics in the United States

J. Fortenberry, J. Ellen, Jiahong Xu, 2016, Journal of acquired immune deficiency syndromes.

Bridging Knowledge Gaps to Understand How Zika Virus Exposure and Infection Affect Child Development

C. Spong, B. Kapogiannis, R. Hazra, 2017, JAMA pediatrics.

Adolescent and young adult research across the HIV prevention and care continua: an international programme analysis and targeted review

B. Kapogiannis, S. Allison, P. Jean‐Philippe, 2023, Journal of the International AIDS Society.

Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth.

J. Sleasman, B. Kapogiannis, Craig M. Wilson, 2012, AIDS patient care and STDs.

Factors Affecting Linkage to Care and Engagement in Care for Newly Diagnosed HIV-Positive Adolescents Within Fifteen Adolescent Medicine Clinics in the United States

J. Fortenberry, J. Ellen, Jiahong Xu, 2014, AIDS and Behavior.

Effect of HIV stigma on depressive symptoms, treatment adherence, and viral suppression among youth with HIV

G. John-Stewart, B. Kapogiannis, K. Agot, 2022, AIDS.

Qualitative Study on the Acceptability of and Adherence to a Vaginal Ring for HIV Prophylaxis Among Adolescent Girls

K. Squires, K. Bunge, K. Mayer, 2021, Journal of acquired immune deficiency syndromes.

Adolescent Self-Consent for Biomedical Human Immunodeficiency Virus Prevention Research.

J. Fortenberry, G. Zimet, A. Gilbert, 2015, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression.

J. Sleasman, B. Kapogiannis, Craig M. Wilson, 2009, AIDS research and human retroviruses.

Using a Designathon to Develop an HIV Self-Testing Intervention to Improve Linkage to Care Among Youths in Nigeria: Qualitative Approach Based on a Participatory Research Action Framework.

J. Iwelunmor, B. Kapogiannis, O. Ezechi, 2023, JMIR Formative Research.

A randomized stepped wedge trial of an intensive combination approach to roll back the HIV epidemic in Nigerian adolescents: iCARE Nigeria treatment support protocol

B. Taiwo, B. Berzins, R. Garofalo, 2023, PLoS ONE.

Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.

S. Woods, S. Nichols, P. Garvie, 2013, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens

B. Kapogiannis, Craig M. Wilson, B. Rudy, 2011, Journal of acquired immune deficiency syndromes.

Linking HIV-positive adolescents to care in 15 different clinics across the United States: Creating solutions to address structural barriers for linkage to care

J. Fortenberry, J. Ellen, B. Kapogiannis, 2014, AIDS care.

Youth-Specific Considerations in the Development of Preexposure Prophylaxis, Microbicide, and Vaccine Research Trials

L. Bekker, G. Gray, P. Krogstad, 2010, Journal of acquired immune deficiency syndromes.

Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.

M. Van Loan, K. Mulligan, C. Stephensen, 2012, The Journal of clinical endocrinology and metabolism.

Accelerating adolescent HIV research in low-income and middle-income countries: evidence from a research consortium

B. Taiwo, J. Iwelunmor, S. Subramanian, 2021, AIDS.

30. Transitioning Adolescents With HIV to Adult Care: Examining Processes at Twelve Adolescent Medicine Clinics

J. Fortenberry, J. Ellen, B. Kapogiannis, 2015 .